Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Why ObsEva Shares Are Trading Higher By Over 70%; Here Are 21 Stocks Moving Premarket

Published 22/11/2022, 11:22
Updated 22/11/2022, 12:40
© Reuters.  Why ObsEva Shares Are Trading Higher By Over 70%; Here Are 21 Stocks Moving Premarket

Benzinga - Gainers

  • ObsEva SA (NASDAQ: OBSV) shares rose 71.9% to $0.2848 in pre-market trading after the company reported the sale of Ebopiprant license agreement to XOMA for up to $113 million.
  • Secoo Holding Limited (NASDAQ: SECO) shares rose 24% to $0.3450 in pre-market trading.
  • Cosmos Holdings Inc. (NASDAQ: COSM) rose 17% to $0.2050 in pre-market trading after jumping 21% on Monday. Cosmos Health agreed to sell its Sky Premium Life Luxury food supplement brand on Iberian Airlines' in-flight magazine, Ronda.
  • Gaotu Techedu Inc. (NYSE: GOTU) shares jumped 13.2% to $1.20 in pre-market trading after the company posted a narrower quarterly loss.
  • Cyclerion Therapeutics, Inc. (NASDAQ: CYCN) rose 12.5% to $0.63 in pre-market trading after gaining around 8% on Monday.
  • Nexalin Technology, Inc. (NASDAQ: NXL) rose 12.2% to $2.30 in pre-market trading after surging around 14% on Monday.
  • First Wave BioPharma, Inc. (NASDAQ: FWBI) rose 8.9% to $0.74 in pre-market trading. First Wave BioPharma reported a private placement.
  • Biofrontera Inc. (NASDAQ: BFRI) rose 8.8% to $1.05 in pre-market trading. Biofrontera will launch Phase 3 clinical study evaluating Ameluz-PDT for the treatment of actinic keratosis on the extremities, neck and trunk.
  • Achieve Life Sciences, Inc. (NASDAQ: ACHV) rose 8% to $2.70 in pre-market trading. Achieve Life Sciences recently reported a private placement of $18.9 million.
  • Esports Entertainment Group, Inc. (NASDAQ: GMBL) rose 7.9% to $0.1080 in pre-market trading after declining over 10% on Monday.
  • EUDA Health Holdings Limited (NASDAQ: EUDA) rose 7.1% to $4.05 in pre-market trading after dipping 15% on Monday.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Losers

  • Gamida Cell Ltd. (NASDAQ: GMDA) fell 18% to $1.46 in pre-market trading after the company issued a regulatory update on Omidubicel. The company said it received extension of Omidubicel PDUFA Date from Jan. 30, 2023 to May 1, 2023 as the FDA issued information request.
  • Hillstream BioPharma, Inc. (NASDAQ: HILS) shares fell 14.7% to $0.4004 in pre-market trading after jumping 10% on Monday.
  • Tantech Holdings Ltd (NASDAQ: TANH) shares fell 13.5% to $1.80 in pre-market trading. Tantech Holdings recently announced a 1-for-24 common share consolidation.
  • Zoom Video Communications, Inc. (NASDAQ: ZM) fell 9.2% to $72.81 in pre-market trading after the company reported better-than-expected results, but issued weak guidance.
  • Drive Shack Inc. (NYSE: DS) shares fell 9.1% to $0.4002 in pre-market trading after jumping 23% on Monday. Drive Shack recently reported Q3 EPS and sales results were higher year over year.
  • Venus Concept Inc. (NASDAQ: VERO) shares fell 9% to $0.1820 in pre-market trading after gaining over 10% on Monday. The company recently posted downbeat quarterly sales.
  • Siyata Mobile Inc. (NASDAQ: SYTA) fell 8.8% to $0.1771 in pre-market trading after jumping 26% on Monday.
  • Canoo Inc. (NASDAQ: GOEV) fell 6.9% to $1.08 in pre-market trading. The company recently posted a narrower-than-expected quarterly loss.
  • Meta Materials Inc. (NASDAQ: MMAT) fell 6.4% to $2.02 in pre-market trading after jumping 30% on Monday. Meta Materials recently posted a Q3 loss of $0.07 per share.
  • Eqonex Limited (NASDAQ: EQOS) fell 6.3% to $0.1965 in pre-market trading after dipping around 24% on Monday.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.